{"entity":{"type":"insider","cik":"0001662411","url":"/insider/0001662411","json_url":"/insider/0001662411.json","name":"Huff James Warren","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":4,"first":"2016-06-02","last":"2023-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Huff James Warren","source":"filing","n_filings":4,"first_seen":"2016-06-02","last_seen":"2023-03-03"}],"transactions":[{"id":7994704,"accession":"0001209191-23-015713","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-23-015713","line_url":"/filing/0001209191-23-015713","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662411","owner_name":"Huff James Warren","owner_display_name":"Huff James Warren","owner_url":"/insider/0001662411","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":85.45963666666667,"price_display":"85.46","price_state":"stated","total_value":6409472.75,"total_display":"6,409,472.75","total_whole":"6,409,473","shares_owned_after":47093.0,"shares_owned_after_display":"47,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-03","scope":"insider","n_lines":11},{"id":2913176,"accession":"0001209191-20-057719","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-057719","line_url":"/filing/0001209191-20-057719#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662411","owner_name":"Huff James Warren","owner_display_name":"Huff James Warren","owner_url":"/insider/0001662411","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64970.0,"shares_display":"64,970","price_per_share":175.0001,"price_display":"175.00","price_state":"stated","total_value":11369756.497,"total_display":"11,369,756.50","total_whole":"11,369,756","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-10","scope":"insider"},{"id":2913174,"accession":"0001209191-20-057719","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-057719","line_url":"/filing/0001209191-20-057719#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662411","owner_name":"Huff James Warren","owner_display_name":"Huff James Warren","owner_url":"/insider/0001662411","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16687.0,"shares_display":"16,687","price_per_share":175.0639,"price_display":"175.06","price_state":"stated","total_value":2921291.2993,"total_display":"2,921,291.30","total_whole":"2,921,291","shares_owned_after":64970.0,"shares_owned_after_display":"64,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider"},{"id":8519526,"accession":"0001209191-19-051083","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-051083","line_url":"/filing/0001209191-19-051083#line-4","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662411","owner_name":"Huff James Warren","owner_display_name":"Huff James Warren","owner_url":"/insider/0001662411","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63000.0,"shares_display":"63,000","price_per_share":86.605,"price_display":"86.60","price_state":"stated","total_value":5456115.0,"total_display":"5,456,115.00","total_whole":"5,456,115","shares_owned_after":94157.0,"shares_owned_after_display":"94,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-27","filed_date":"2019-09-30","scope":"insider"},{"id":2068871,"accession":"0000899243-16-021419","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-16-021419","line_url":"/filing/0000899243-16-021419#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662411","owner_name":"Huff James Warren","owner_display_name":"Huff James Warren","owner_url":"/insider/0001662411","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":114000.0,"shares_display":"114,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1254000.0,"total_display":"1,254,000.00","total_whole":"1,254,000","shares_owned_after":176657.0,"shares_owned_after_display":"176,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Director, Officer (Chief Executive Officer)","n_filings":4,"first_seen":"2016-06-02","last_seen":"2023-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001662411","retrieved_at":"2026-08-26T20:52:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}